Kishechnaya gemorragiya pri NPVP-indutsirovannom porazhenii pishchevaritel'noy trubki
- Authors: Evseev M.A1
-
Affiliations:
- ММА им. И.М.Сеченова
- Issue: Vol 11, No 9 (2009)
- Pages: 82-86
- Section: Articles
- URL: https://bakhtiniada.ru/2075-1753/article/view/93055
- ID: 93055
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##References
- Bjarnason I, Zanelli G, Prouse P et al. Effect of non - steroidal anti - inflammatory drugs on the human small intestine. Drugs 1999; 32 (Suppl.): 35–41.
- Moore R.A., Derry S, Mc Quay H. What do we know about communication risk? A brief review and suggestion for contextualizing serious? But rare? Risk, and the example of cox - 2 selective and non - selective NSAIDs. Arthritis Res Ther 2008; 10: R20.
- Morris A.J., Wasson L.A., Mackenzie J.F. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss Gut 1992; 887–9.
- Kessler W.F., Shires G.T. 3rd, Fahey T.J. 3rd. Surgical complications of nonsteroidal antiinflammatory drug - induced small bowel ulceration. J Am Coll Surg 1997; 185 (3): 250–4.
- Lanas A, Garcia-Rodrigues L.A., Polo-Tomas M. Time trends and impact of upper and lower gastrointestinal bleeding in clinical practice. Am J Gastroent 2009, 10: 1038–164.
- Allison M.C., Howatson A.G., Torrance C.J. et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992; 327: 751–6.
- Mс Adam B.F., Catella-Lawson E, Mardini I.A. et al. Systemic biosynthesis of prostacyclin by cyclooxigenase (COX) - 2: the human pharmacology of a selective inhibitors of COX-2. PNAS 1999; 96: 272–7.
- Bjarnason I, Zanelli G, Smith T et al. Nonsteroidal antiinflammatory drug - induced intestinal inflammation in humans. Gastroenterology 1987; 93: 480–9.
- Collins A.J., Du Toit J.A. Upper gastrointestinal findings and faecal occult blood in patients with rhumatic diseases taking nonsteroidal anti - inflmmatory drugs. Br J Rheumatol 1987; 26: 295–8.
- Holt S, Rigoglioso V, Sidhu M et al. Nonsteroidal antiinflammatory drugs and lower gastrointestinal bleeding. Dig Dis Sci 1993; 38: 1619–23.
- Aabakken L, Larsen S, Osnes M. Sucralfate for prevention of naproxen - induced mucosal lesions in the proximal and distal gastrointestinal tract. Scand J Rheumatol 1989; 18: 361–8.
- Aabakken L, Larsen S, Osnes M. Cimetidine tablets or suspension for the prevention of gastrointestinal mucosal lesions caused by non - steroidal anti - inflammatory drugs. Scand J Rheumatol 1989; 18: 369–75.
- Bjarnason I, Smethurst P, Fenn C.G. et al. Misoprostol reduces indomethacininduced changes in human small intestinal permeability. Dig Dis Sci 1989; 34: 407–11.
- Bjarnason I. Experimental evidence of the benefit of misoprostol beyond the stomach in humans. J Rheumatol 1990; (Suppl. 20) 17: 38–41.
- Davies G.R., Wilkie M.E., Rampton D.S. Effects of metronidazole and misoprostol on indomethacin - induced changes in intestinal permeability. Dig Dis Sci 1993; 38: 417–25.
- Jenkins R.T., Rooney P.J., Hunt R.H. Increased bowel permeability to [51Cr]EDTA in controls caused by Naproxen is not prevented by cytoprotection. Arth Rheum 1988; 31 (Suppl. 1): R11.
- Goldstein J.L., Silverstein F.E., Agrawal N.M. et al. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX - 2 inhibitor. Am J Gastroenterol 2000; 95: 1681–90.
- Leese P, Hubbard R, Karim A. Effects of celecoxib on a platelet Function in adults. J Clin Pharmacol 2000; 40: 124.
Supplementary files
